NCT00032877

Brief Summary

This study will examine blood or other tissue samples from patients with Fraser syndrome and patients with Fryns syndrome to try to identify the gene responsible for these diseases. Fraser syndrome is characterized by congenital abnormalities including cryptophthalmos (lack of eyelid formation), syndactyly (webbed fingers or toes) and abnormal genitalia. Patients may also have abnormalities of the nose, ears and larynx (voice box), cleft lip or palate, and kidney agenesis. Fryns syndrome is characterized by hernia through the diaphragm, cloudy cornea, coarse facial features, cleft lip or palate, abnormal fingers and toes, heart, kidney and brain malformations and hydrocephalus (accumulation of fluid around the brain). This protocol consists of laboratory study only; it does not involve patient care or patient counseling. Patients with Fraser syndrome or Fryns syndrome are eligible for this study. Parents and healthy siblings of patients will also be included for genetic study, and parents of children with undiagnosed multiple congenital anomalies syndromes will be included for comparison study. Participants will provide a blood sample (about 8 to 10 teaspoons from adults; 1 to 3 teaspoons from children) or sample of skin cells collected by swabbing the inner surface of the cheek. Some patients may undergo a skin biopsy, in which a small skin sample (about 1/8-inch in diameter) is surgically removed. The tissue samples will be used to obtain DNA (genetic material) for laboratory testing. A permanent cell line-a collection of cells grown in the laboratory from the original tissue specimen-will also be established to enable additional testing in the future.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
400

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2002

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2002

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

April 4, 2002

Completed
1 day until next milestone

First Posted

Study publicly available on registry

April 5, 2002

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2003

Completed
Last Updated

March 4, 2008

Status Verified

February 1, 2003

First QC Date

April 4, 2002

Last Update Submit

March 3, 2008

Conditions

Keywords

Linkage StudyGene Identification StudyDiaphragmatic HerniaFraser SyndromeCryptophthalmosFryns SyndromeHydrolethalus SyndromePositional Cloning

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Satisfying diagnostic criteria for Fraser syndrome. These are at least two major criteria and one minor criterion (listed below) or one major criterion and four minor criteria.
  • Major criteria:
  • Cryptophthalmos
  • Syndactyly
  • Abnormal genitalia
  • Sib with cryptophthalmos syndrome
  • Minor criteria:
  • Congenital malformation of the nose
  • Congenital malformations of the ears
  • Congenital malformation of the larynx
  • Cleft lip and/or palate
  • Skeletal defects
  • Umbilical hernia
  • Renal agenesis
  • Mental retardation
  • +4 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Human Genome Research Institute (NHGRI)

Bethesda, Maryland, 20892, United States

Location

Related Publications (3)

  • Acosta JM, Chai Y, Meara JG, Bringas P Jr, Anderson KD, Warburton D. Prenatal exposure to nitrofen induces Fryns phenotype in mice. Ann Plast Surg. 2001 Jun;46(6):635-40. doi: 10.1097/00000637-200106000-00012.

    PMID: 11405365BACKGROUND
  • Andiran F, Tanyel FC, Hicsonmez A. Fraser syndrome associated with anterior urethral atresia. Am J Med Genet. 1999 Feb 12;82(4):359-61. doi: 10.1002/(sici)1096-8628(19990212)82:43.0.co;2-q. No abstract available.

    PMID: 10051174BACKGROUND
  • Balci S, Altinok G, Ozaltin F, Aktas D, Niron EA, Onol B. Laryngeal atresia presenting as fetal ascites, olygohydramnios and lung appearance mimicking cystic adenomatoid malformation in a 25-week-old fetus with Fraser syndrome. Prenat Diagn. 1999 Sep;19(9):856-58. doi: 10.1002/(sici)1097-0223(199909)19:93.0.co;2-x.

    PMID: 10521845BACKGROUND

MeSH Terms

Conditions

Fraser SyndromeFryns syndromeChromosome AberrationsAbnormalities, MultipleHernia, DiaphragmaticHydrolethalus syndrome

Condition Hierarchy (Ancestors)

SyndactylySynostosisDysostosesBone Diseases, DevelopmentalBone DiseasesMusculoskeletal DiseasesLimb Deformities, CongenitalMusculoskeletal AbnormalitiesEye AbnormalitiesEye DiseasesUrogenital AbnormalitiesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesPathologic ProcessesPathological Conditions, Signs and SymptomsInternal HerniaHerniaPathological Conditions, Anatomical

Study Design

Study Type
observational
Sponsor Type
NIH

Study Record Dates

First Submitted

April 4, 2002

First Posted

April 5, 2002

Study Start

April 1, 2002

Study Completion

February 1, 2003

Last Updated

March 4, 2008

Record last verified: 2003-02

Locations